VYNE Therapeutics Inc. (VYNE): SCHEDULE 13G filed Aug 3, 2026

Form type

SCHEDULE 13G

Filing date

Aug 3, 2026

Accession number

0001193125-26-330498

Filer

VYNE Therapeutics Inc. (CIK 1566044)